James Fleming

James Fleming is a Cell Line Development Scientist at AstraZeneca, specialising in molecular biology with a focus on plasmid design and how regulatory elements and emerging technologies can enhance biotherapeutic expression. With over five years of industry experience, including previous roles at Revvity and bit.bio, they are also a keen footballer who recently ran 60 miles in July for Cancer Research UK.